Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Yuki Fujiwara to Prognosis

This is a "connection" page, showing publications Yuki Fujiwara has written about Prognosis.

 
Connection Strength
 
 
 
0.227
 
  1. Yamada H, Yamada R, Komohara Y, Pan C, Yoshii D, Yano H, Matsubara E, Shinchi Y, Tsukamoto H, Fujiwara Y, Ikeda K, Suzuki M. Integrative analysis of T cell subset-specific ICOS expression and tumor HLA class I/II expression in lung adenocarcinoma: implications for their interaction and clinical outcome. Cancer Immunol Immunother. 2026 Feb 28; 75(3).
    View in: PubMed
    Score: 0.032
  2. Sakaida N, Yamada R, Arima K, Yamashita K, Hanada N, Yoshii D, Fujiwara Y, Nakashita C, Shimoda S, Iwatsuki M, Komohara Y. Relationship between nutritional indicators and clinicopathological factors, including immune cell densities in the tumor microenvironment, in patients with colorectal cancer. Med Mol Morphol. 2026 Jun; 59(2):113-123.
    View in: PubMed
    Score: 0.031
  3. Ishida H, Rodriguez Franco S, Franklin O, Fujiwara Y, Khomiak A, Balmaceda NB, Pellegrini R, Mungo B, Schulick RD, Del Chiaro M. Neoadjuvant Therapy for Invasive Intraductal Papillary Mucinous Neoplasms: A Comparative Study With Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol. 2026 Mar; 33(3):2620-2631.
    View in: PubMed
    Score: 0.031
  4. Ezaki A, Yano H, Pan C, Fujiwara Y, Anami T, Ibe Y, Ozaki Y, Nishizawa H, Motoshima T, Yatsuda J, Watanabe H, Maruyama T, Takeo T, Kamba T, Komohara Y. Immunohistochemical Analysis of a1-Acid Glycoprotein and Tumor Associated Macrophages in Clear Cell Renal Cell Carcinoma. Cancer Genomics Proteomics. 2025 Jan-Feb; 22(1):103-111.
    View in: PubMed
    Score: 0.029
  5. Nishitsuji K, Mito R, Ikezaki M, Yano H, Fujiwara Y, Matsubara E, Nishikawa T, Ihara Y, Uchimura K, Iwahashi N, Sakagami T, Suzuki M, Komohara Y. Impacts of cytoplasmic p53 aggregates on the prognosis and the transcriptome in lung squamous cell carcinoma. Cancer Sci. 2024 Sep; 115(9):2947-2960.
    View in: PubMed
    Score: 0.028
  6. Saito Y, Fujiwara Y, Miyamoto Y, Ohnishi K, Nakashima Y, Tabata Y, Baba H, Komohara Y. CD169+ sinus macrophages in regional lymph nodes do not predict mismatch-repair status of patients with colorectal cancer. Cancer Med. 2023 05; 12(9):10199-10211.
    View in: PubMed
    Score: 0.026
  7. Matsubara E, Komohara Y, Shinchi Y, Mito R, Fujiwara Y, Ikeda K, Shima T, Shimoda M, Kanai Y, Sakagami T, Suzuki M. CD163-positive cancer cells are a predictor of a worse clinical course in lung adenocarcinoma. Pathol Int. 2021 Oct; 71(10):666-673.
    View in: PubMed
    Score: 0.023
  8. Saito Y, Ohnishi K, Miyashita A, Nakahara S, Fujiwara Y, Horlad H, Motoshima T, Fukushima S, Jinnin M, Ihn H, Takeya M, Komohara Y. Prognostic Significance of CD169+ Lymph Node Sinus Macrophages in Patients with Malignant Melanoma. Cancer Immunol Res. 2015 Dec; 3(12):1356-63.
    View in: PubMed
    Score: 0.015
  9. Komohara Y, Hasita H, Ohnishi K, Fujiwara Y, Suzu S, Eto M, Takeya M. Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma. Cancer Sci. 2011 Jul; 102(7):1424-31.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)